Agencies and industry organizations directly post original announcements on Adweek Wire. Adweek does not review or edit these announcements.

iSpot Data Reveals Just How Much Pharma Brands Are Spending on TV Advertising

Mounjaro and Ozempic, diabetes drugs being touted by Hollywood and TikTok for powerful off-label weight loss capabilities, are two of the newest top-spending brands

In March, prescription pharmaceutical brands spent an estimated $403.4 million on national TV advertising, according to recently released data from iSpot.tv, the real-time TV measurement company. That’s almost twice as much as the second top-spending category for the month, automakers (est. $216.1 million), and a 16% increase from prescription pharma’s February outlay.

The subcategory of medication for psoriasis, skin & nails led the charge with an estimated $95.8 million on TV advertising. Across all pharma categories, AbbVie’s JAK inhibitor drug Rinvoq led the ranking of the top ten individual brands by estimated TV ad spend (est. $32.4 million), followed by Skyrizi, another drug from AbbVie, with $30.5 million. Paxlovid, Pfizer’s COVID-19 antiviral that received FDA committee support for full approval in mid-March, took third place with $30 million in estimated TV ad spend for the month, up from $16.3 million in February when national ads for it hit TV screens for the first time.

Month-over-month ranking newcomers included two diabetes drugs: Eli Lilly’s Mounjaro in fifth place with an estimated TV ad spend of $21.4 million, and Novo Nordisk’s Ozempic (No. 10, est. $10.1 million). Ozempic jumped into headlines last fall as an off-label miracle weight-loss drug being used by the rich and famous, and more recently Mounjaro has joined the news cycle with some declaring it the latest trendy contender to cure obesity.

Examining how Rx brands are prioritizing TV ad spend, news programming is a key area: Combined, the pharma industry spent nearly $15 million advertising during ABC World News Tonight With David Muir in March, generating 986.7 million TV ad impressions. NBC Nightly News With Lester Holt, Good Morning America, CBS Evening News With Norah O’Donnell, Today and CBS Mornings also were in the top ten programs by spend for the industry.

News aside, pharma did not ignore March tentpole events: the industry spent $13 million on men’s college basketball, making it the No. 2 program for spend, and $10.5 million on airings during The Oscars telecast.

iSpot.tv is a cross-platform TV measurement company trusted by brands, networks and agencies to deliver fast, accurate and actionable information the marketplace can use to transact. Its real-time, always-on platform measures all phases of the TV advertising lifecycle from creative testing to audience verification, to business outcomes and brand impact, empowering brands to justify, optimize and invest with confidence. iSpot persistently measures TV-device impressions and second-by-second attention for all TV ads in a unified manner across linear, time-shifted, VOD, streaming environments and out-of-home (OOH) environments. A trusted currency provider for networks, ad-delivery platforms and agencies, iSpot uses its proprietary systems for bringing transparency into TV advertising at unparalleled scale. The company delivers its solution in real time via intuitive and modern dashboards as well as APIs and customized analytics. iSpot.tv has hundreds of brands and all major TV networks licensing its enterprise solution and has become a trusted currency for networks, brands and agencies. Founded in Bellevue, Washington in 2012, iSpot has offices in major cities across America.